查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790461

美國血酮儀市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. Blood Ketone Meter Market Size, Share & Trends Analysis Report By Type (Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, Consumables), By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國血酮監測市場概況

美國血酮監測儀市場規模預計在 2024 年為 1.061 億美元，預計到 2033 年將達到 1.151 億美元，2025 年至 2033 年的複合年成長率為 0.9%。推動市場成長的因素包括糖尿病盛行率的上升、消費者健康意識的增強以及生酮和低碳水化合物飲食的普及。

成長的動力源於人們對代謝健康管理日益成長的興趣，尤其是在生酮人群和需要監測的人群中。血酮監測儀用於監測酮水平，例如管理第1型糖尿病 (T1D)、追蹤生酮飲食中的營養性酮症，以及支持治療癲癇等神經系統疾病。 2023年的一項名為「床邊毛細血管血酮測量與1型糖尿病未來酮症酸中毒風險預測」的研究，探討了在空腹、無症狀的1型糖尿病患者中，常規床邊毛細血管血酮測量能否預測未來發生糖尿病酮症酸中毒 (DKA) 的可能性。

結果表明，常規毛細血管酮體監測有助於識別未來糖尿病酮症酸中毒 (DKA) 高風險族群，凸顯了持續酮體監測 (CKM) 等新興技術在早期療育和預防方面的潛在價值。隨著人們對 DKA 預防意識的不斷提高，此類證據有望推動美國血酮儀市場的普及和擴張。

美國血酮監測產業正受到不斷發展的醫療服務模式和支付方政策改革的影響。遠端醫療的興起主要得益於新冠疫情，它透過實現遠距諮詢、即時數據共用和及時治療調整，使糖尿病管理更加便捷。這項轉變有助於更持續地使用血酮監測儀等監測工具，尤其對於管理第1型糖尿病 (T1D) 並堅持生酮飲食的患者。至2024年，美國20歲以下兒童和青少年中將新增約2萬例第1型糖尿病 (T1D) 病例。這一成長是由遺傳風險、環境因素和早期生活方式的改變（例如飲食和感染疾病）所推動的。

MDPI 2025 研究題為“1 型糖尿病兒童重度糖尿病酮酸症”，強調了一項關於酮體監測的重要發現。研究發現，在早期發現和管理 DKA 方面，血酮檢測比尿酮檢測更有效。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國血酮儀市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國血酮監測儀市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
  • 美國血酮儀市場：通路分析

第4章美國血酮儀市場：按類型、估計和趨勢分析

  • 類型細分儀表板
  • 美國血酮儀市場：類型變化分析
  • 美國血酮儀市場規模及趨勢分析（2021-2033）
  • 血酮監測
  • 監測血糖值和酮體
  • 耗材

第5章美國血酮儀市場：應用、估計與趨勢分析

  • 應用程式細分儀表板
  • 美國血酮監測儀市場：應用差異分析
  • 2021-2033年美國血酮儀市場規模及應用趨勢分析
  • 人類
  • 獸醫

第6章美國血酮儀市場：依最終用途的估計和趨勢分析

  • 最終用途細分儀表板
  • 美國血酮儀市場：最終用途差異分析
  • 2021 年至 2033 年美國血酮儀市場規模及趨勢分析（依最終用途）
  • 醫院
  • 診斷中心
  • 居家照護
  • 其他

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Abbott
    • Apex BIoTechnology Corp.
    • TaiDoc Technology Corporation
    • EKF Diagnostic Holdings plc.
    • Nova Biomedical
    • Keto-Mojo
    • ForaCare, Inc.
    • Nipro
    • I-SENS, Inc
Product Code: GVR-4-68040-679-2

U.S. Blood Ketone Meter Market Summary

The U.S. blood ketone meter market size was estimated at USD 106.1 million in 2024 and is projected to reach USD 115.1 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. Some of the factors contributing to market growth include the increasing prevalence of diabetes, growing health awareness among consumers and rising adoption of ketogenic and low-carbohydrate diets.

The growth is driven by increasing interest in metabolic health management, particularly within the keto diet community and among people who need to monitor Blood ketone meters are used to monitor ketone levels for managing Type 1 Diabetes (T1D), tracking nutritional ketosis in ketogenic diets, and supporting the treatment of neurological conditions such as epilepsy. A 2023 study titled "Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes" investigated whether routine point-of-care capillary blood ketone measurements in fasted, symptom-free individuals with T1D could predict future DKA events.

The findings showed that routine capillary ketone monitoring can help identify individuals at elevated risk of future DKA, highlighting the potential value of emerging technologies such as Continuous Ketone Monitoring (CKM) for early intervention and prevention. With the growing awareness of DKAprevention, such evidence will likely broaden the adoption and expansion of the U.S. blood ketone meter market.

The U.S. blood ketone meter industry is shaped by evolving care delivery models and payer policy reforms. The rise of telehealth, boosted significantly by the COVID-19 pandemic, has made diabetes management more accessible by enabling remote consultations, real-time data sharing, and timely treatment adjustments. This shift supports more consistent use of monitoring tools such as blood ketone meters, especially for patients managing T1D or adhering to ketogenic therapies. In 2024, approximately 20,000 children and adolescents under the age of 20 in the U.S. were newly diagnosed with T1D. This increase is driven by inherited risk, environmental factors, and changes in early-life habits (such as diet and infections).

The MDPI 2025 study titled "Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes" highlighted key findings on ketone monitoring. The study found that blood ketone testing was more effective than urine ketone testing in early DKA detection and management.

U.S. Blood Ketone Meter Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. blood ketone meter market report based on type, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
    • Blood Ketone Monitoring
    • Blood Glucose and Ketone Monitoring
    • Consumables
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Humans
    • Veterinary
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals
    • Diagnostic Centers
    • Home Care Settings
    • Other

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Gender
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Blood Ketone Meter Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Blood Ketone Meter Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape
  • 3.4. U.S. Blood Ketone Meter Market: Pipeline Analysis

Chapter 4. U.S. Blood Ketone Meter Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. Blood Ketone Meter Market: Type Movement Analysis
  • 4.3. U.S. Blood Ketone Meter Market Size & Trend Analysis, by type, 2021 - 2033 (USD Million)
  • 4.4. Blood Ketone Monitoring
    • 4.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 4.5. Blood Glucose and Ketone Monitoring
    • 4.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 5. U.S. Blood Ketone Meter Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Blood Ketone Meter Market: Application Movement Analysis
  • 5.3. U.S. Blood Ketone Meter Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
  • 5.4. Humans
    • 5.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.5. Veterinary
    • 5.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 6. U.S. Blood Ketone Meter Market: End Use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. U.S. Blood Ketone Meter Market: End Use Movement Analysis
  • 6.3. U.S. Blood Ketone Meter Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2021 - 2033 (USD million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.6. Home Care Settings
    • 6.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Apex Biotechnology Corp.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. TaiDoc Technology Corporation
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. EKF Diagnostic Holdings plc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Nova Biomedical
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Keto-Mojo
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. ForaCare, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Nipro
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. I-SENS, Inc
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Type benchmarking
      • 7.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. blood ketone meter market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. blood ketone meter market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. blood ketone meter market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. blood ketone meter market: market outlook
  • Fig. 10 U.S. blood ketone meter competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. blood ketone meter market driver impact
  • Fig. 16 U.S. blood ketone meter market restraint impact
  • Fig. 17 U.S. blood ketone meter market strategic initiatives analysis
  • Fig. 18 U.S. blood ketone meter market: type movement analysis
  • Fig. 19 U.S. blood ketone meter market: type outlook and key takeaways
  • Fig. 20 Blood ketone monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Blood glucose and ketone monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. blood ketone meter market: application movement analysis
  • Fig. 24 U.S. blood ketone meter market: application outlook and key takeaways
  • Fig. 25 Humans estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Veterinary estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. blood ketone meter market: end use movement analysis
  • Fig. 28 U.S. blood ketone meter market: end use outlook and key takeaways
  • Fig. 29 Hospitals estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Diagnostic Centers estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Home care settings estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Others estimates and forecast, 2021 - 2033 (USD Million)